Six public health experts are being considered for the World Health Organization’s top job.

Scientists search for Zika immunity; archaea, bacteria, and viruses in the deep sea; antibody shows promise for controlling SIV; CRISPR-edited stem cells correct sickle cell mutation; OpenTrials launch

Forgotten bacterium; talc and cancer risk; innocuous mutations

Ambry Genetics CEO Aaron Elliott discusses his team’s recent analysis of 20,000 clinical next-generation sequencing panels.

Nobels for autophagy research and molecular machines; PubPeer in court; neuronal migration in newborn brains; childhood stress and telomere length later in life; Theranos restructuring 

The blood-testing company is shutting down clinical labs, laying off more than 300 employees across three states.

CRISPR-based noncoding genomic screening techniques; Congress passes Zika funding; “revolving door” between FDA and industry careers; more publications, more citations?

Researchers report conflicting results.

World leaders agree to fight superbugs; researchers edit human embryos; peer reviewers’ motivations

Congress’s failure to fund Zika response; another DNA vaccine against Zika shows promise; convergent evolution of caffeine production in plants; MacArthur “Geniuses” announced; Thomson Reuters issues Nobel predictions

The agency OKs Sarepta Therapeutics’s treatment for Duchenne muscular dystrophy through its accelerated approval pathway, which requires a confirmatory clinical trial.

Human-Neanderthal inbreeding; “personal genetics” is a family matter; studying city-dwelling rats; science reporting without embargoes